行情

VNRX

VNRX

VOLITIONRX
AMEX

实时行情|Nasdaq Last Sale

5.49
+0.12
+2.23%
休市 16:00 11/15 EST
开盘
5.41
昨收
5.37
最高
5.54
最低
5.37
成交量
9.06万
成交额
--
52周最高
6.84
52周最低
1.670
市值
2.26亿
市盈率(TTM)
-11.4208
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

VNRX 新闻

  • 花旗策略师:美股明年面临四大障碍
  • 新浪美股.4小时前
  • 三大指数提供商最快在12月将沙特阿美纳入其指数
  • 新浪美股.6小时前
  • 日韩企业联手 韩媒:将对阿里腾讯构成巨大威胁
  • 参考消息.8小时前
  • 外媒:流媒体平台如何改变人们看电视的方式
  • 参考消息.8小时前

更多

所属板块

医疗设备、用品及经销
+1.05%
医疗设备和用品
+1.69%

热门股票

名称
价格
涨跌幅

VNRX 简况

VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease. The Company's Nucleosomics biomarker platform is a technology that is used for a range of cancers. The Company is developing Nucleosomics tests for various cancers, including colorectal, pancreatic, lung and aggressive prostate. The Company's NuQ blood assays fall into over five types, which include NuQ-X, NuQ-V, NuQ-M, NuQ-A and NuQ-T. It has developed approximately two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides.
展开

Webull提供VolitionRX Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。